Rock Star Growth Puts Arcutis Biotherapeutics (NASDAQ:ARQT) In A Position To Use Debt
Insider Selling: Director Howard Welgus Sells 10,000 Shares of Arcutis Biotherapeutics Inc (ARQT)
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Arcutis Completes Enrollment of Phase 1B Alopecia Areata Study Evaluating Arq-255
Arcutis Completes Enrollment of Phase 1b Alopecia Areata Study Evaluating ARQ-255
Daily options tracking | Nvidia put ratio rising! Big players aggressively buying $100 forward call options; United States Steel options trading surges, one put option makes a huge profit of 25 times.
Tesla's overnight surge more than 4%, options trading volume of about 1.7 million contracts, a 27% increase compared to the previous trading day's volume, put options significantly increased compared to the previous day, reaching 48.3%.